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Abstract
Septic pulmonary embolism (SPE) is an uncommon, but life-
threatening event that is usually associated with extrapulmonary
infections. We report the ﬁrst case of bilateral SPE secondary to
a central venous catheter-related bloodstream infection involving
pathogens commonly considered environmental contaminants:
Tsukamurella tyrosinosolvens and Rhizobium radiobacter. Empirical
levoﬂoxacin treatment was conﬁrmed by in vitro susceptibility
data and produced prompt clinical improvement, but removal of
the infected line proved indispensable for eradication of the
infection. Laboratory personnel should be aware of the patho-
genic potential of these environmental organisms, particularly in
immunocompromised hosts with indwelling catheters.
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Septic pulmonary embolism (SPE) involves the occlusion of
one or more pulmonary arteries by bacterial or fungal
thrombi, which causes ischaemic damage as well as infectious
complications [1]. An uncommon event, SPE is often difﬁcult
to diagnose. The presentation varies with the organism and
the underlying disease, but ﬁndings are often non-speciﬁc:
fever and lung inﬁltrates associated with an active focus of
infection—generally extrapulmonary.
Thanks to improved diagnosis and treatment, the mortal-
ity associated with SPE has decreased, but its incidence is
increasing, especially among immunocompromised patients
[1]. Intravenous drug abuse, thrombophlebitis affecting pelvic
veins or the internal jugular, and endocarditis were once the
major risk factors for SPE, but most cases are now related
to infected intravascular devices or catheters and soft-tissue
infections, frequently caused by Staphylococcus aureus, coagu-
lase-negative staphylococci or Fusobacterium spp. [1–5].
We observed a rare case of SPE in a 70-year-old white
man with an indwelling Groshong-like central venous cathe-
ter (CVC). Two years before admission, he had a right pul-
monary lobectomy for squamous-cell carcinoma, and the
CVC had been inserted 6 months later for administration of
chemotherapy. He presented with fever (39.5C), shaking
chills, dyspnoea, mild chest pain, 8350 white blood cells per
mm3 (89% neutrophils); 154 000 platelets per mm3; 9.0 g
haemoglobin per dL; and a C-reactive protein level of
118 mg/L. Computed tomography (CT) demonstrated nod-
ules in both lungs (Fig. 1a). The echocardiogram revealed no
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valvular vegetations, and there were no clinical or radio-
graphic signs of deep-vein thrombosis. The sputum contained
normal ﬂora with no evidence of mycobacteria or moulds.
Four sets of blood cultures were drawn (two through the
CVC), and empirical therapy was started with levoﬂoxacin
(500 mg/day intravenously).
All four aerobic blood cultures were positive at the 24-h
reading. Positivity was observed >120 min earlier in specimens
collected from the CVC. All four vials grew mixed ﬂora com-
prising Gram-positive and Gram-negative bacilli. The former
produced irregular yellowish colonies on blood agar that were
rough, dry and easily emulsiﬁed, which were misidentiﬁed as
Rhodococcus species by the API CORYNE system (BioMe´rieux,
Marcy L’Etoile, France). Full-length 16S rRNA gene sequencing
revealed 100% similarity with the prototype sequence of Tsuk-
amurella tyrosinosolvens strain IFM 10623 (AB478956) (http://
www.ncbi.nlm.nih.gov/BLAST/). This ﬁnding was consistent
with the results of conventional biochemical testing including
the ability to hydrolyse tyrosine and no growth at 42C.
The Gram-negative isolates were identiﬁed by the Vitek 2
and the API 20NE systems (BioMe´rieux) as Rhizobium radio-
bacter (both with probabilities of 99%). Sequence analysis of
the 16S rRNA gene showed 99% homology with Agrobacte-
rium tumefaciens (Rhizobium radiobacter) strain A2P3 (http://
www.ncbi.nlm.nih.gov/BLAST/). Table 1 shows E-test minimum
inhibitory concentrations for both isolates. Levoﬂoxacin was
continued, and body temperature and C-reactive protein lev-
els slowly normalized. Two weeks after admission, CT
showed progressive reduction of the nodular lesions (Fig. 1b).
Levoﬂoxacin was discontinued on day 28, but 5 days later the
patient’s fever returned. The CVC was removed and cultured
using a semi-quantitative technique [6], and levoﬂoxacin was
restarted. The CVC tip culture yielded > 15 colony-forming
units of T. tyrosinosolvens and R. radiobacter. After 14 more
days of levoﬂoxacin, the patient was well. No signs of infec-
tion were observed at the 6-month follow-up visit.
As this case illustrates, SPE can present with non-speciﬁc
ﬁndings. Blood cultures, chest CT, and echocardiography are
invaluable when SPE is suspected. The pathogens responsible
for our patient’s SPE are rarely implicated in human infections
and often considered mere environmental contaminants.
Systemic T. tyrosinosolvens infections were ﬁrst reported in
patients with cardiac pacemaker implants [7]. Since then,
T. tyrosinosolvens has been implicated in three cases of cathe-
ter-related bacteraemia, two ophthalmological infections, one
case of bacteraemic pneumonia, and one brain abscess [8–14].
The true frequency of Tsukamurella infections may be higher.
The bacilli can easily be dismissed as diptheroid contaminants
or included among unidentiﬁed Gram-positive bacilli. Species-
(a) (b)
FIG. 1. Computed tomography images of the chest. (a) At admission multiple subpleural nodules were present in both lung ﬁelds with diameters
ranging from a few millimetres to 1 cm (a); Repeat scan performed after 2 weeks of levoﬂoxacin therapy showing reduction of the nodular
lesions (b).
TABLE 1. Susceptibility to different antimicrobial agents of
Tsukamurella tyrosinosolvens and Rhizobium radiobacter iso-
lates
Antimicrobial agent
Minimum inhibitory
concentration (mg/L)
T. tyrosinosolvens R. radiobacter
Penicillin >32 NT
Ceftazidime >256 0.5
Imipenem 0.25 0.047
Meropenem NT 0.094
Piperacillin/tazobactam >256 0.023
Levoﬂoxacin 0.19 0.032
Tetracycline 2 0.125
Claritromycin 2 NT
Linezolid 0.5 NT
Teicoplanin 1 NT
Quinupristin/Dalfopristin >32 NT
NT, not tested.
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level identiﬁcation of Tsukamurella isolates is unreliable with
many commercial systems used in microbiology laboratories,
and additional manual tests are labour-intensive and time-
consuming. In our case, the phenotypic identiﬁcation was
conﬁrmed by sequence analysis of the 16S rRNA gene. How-
ever, other authors have found that even this approach may
prove to be insufﬁciently discriminatory because of small dif-
ferences in the 16S rRNA gene sequence in various Tsukamu-
rella species [12,13]. As for the Rhizobium/Agrobacterium
group, it includes aerobic, oxidase-positive, motile, non-
glucose-fermenting, non-spore-forming, Gram-negative bacilli
that are ubiquitous in water and soil. Rhizobium radiobacter has
been isolated in several catheter-related infections, particu-
larly in immunocompromised patients [15–18].
Antimicrobial regimens for SPE should be based on micro-
biological testing. The susceptibility proﬁles of Tsukamurella
[8,12] and Rhizobium [15,17,18] isolates are consistent with
our experience in the present case. It is difﬁcult to identify
an optimal antimicrobial regimen for Tsukamurella infections,
given their rarity. Those reported have been treated with a
b-lactam agent (including carbapenem) plus an aminoglyco-
side or a rifamycin [8,11]. Empirical treatment with levoﬂox-
acin, which is routine practice in our hospital for febrile
cancer patients, was a valid choice in our patient, as demon-
strated by the clinical response and by in vitro susceptibility
data. Information on ﬂuoroquinolone therapy for Tsukamurel-
la infections is limited [19]. Eye infections have been treated
successfully with levoﬂoxacin drops [14], and ciproﬂoxacin
combined with clarithromycin and trimethoprim-sulfameth-
oxazole was used as maintenance therapy for a patient
whose Tsukamurella brain abscess had been eradicated with
imipenem and amikacin (plus debridement) [12]. Ciproﬂoxa-
cin has also been proposed as the drug of choice for sys-
temic R. radiobacter infections [15].
Successful management of SPE also requires discovery of
the source of the septic emboli. In theory, the CVC may have
been colonized during bacteraemia originating from another
focus, but there is substantial evidence that the source of
infection was the CVC itself. It had been in place for
18 months and was regularly ﬂushed by the patient and his
wife, a practice that would facilitate contamination with envi-
ronmental organisms [15]. The catheter’s role is also sup-
ported by the early positivity of blood cultures drawn from
the CVC, the positive result of the semi-quantitative catheter
culture, the treatment failure observed when the catheter was
still in place, and the success achieved after its removal [6,20].
The use of intravascular devices is increasing, and infections
related to these appliances are becoming more common. The
possibility of SPE should be considered, even when the infec-
tion is caused by environmental or opportunistic pathogens.
Nucleotide sequence accession number
The sequences of the Gram-positive and Gram-negative
isolates evaluated in this study have been deposited within
the GenBank sequence database under accession number
GU230849 and FR669127, respectively.
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